CRSP
CRISPR Therapeutics AG$52.15+1.15 (+2.25%)Prev Close$50.99·MCap$4.68B·P/E—·Vol1.14M·Yield—
▲
Buys (12M)
2
$52.64M
▼
Sells (12M)
11
$14.81M
◆
Net Activity
Net Buyer
$37.83M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at CRISPR Therapeutics AG (CRSP) has been dominated by buying, with 2 insider purchases totaling $52.64M and 11 insider sales totaling $14.81M. The most recent insider transaction was by KASINGER JAMES R. (General Counsel and Secretary), who sold $111.0K worth of shares on Feb 18, 2026. CRISPR Therapeutics AG operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.68B.
CRSP Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,112 | $52.58 | $111.0K | 0 |
| Feb 18, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 6,967 | $52.58 | $366.3K | 0 |
| Jan 22, 2026 | Prasad Raju | Chief Financial Officer | Sell | 34,972 | $60.19 | $2.10M | 0 |
| Jan 20, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 90,000 | $57.40 | $5.17M | 0 |
| Jan 6, 2026 | Prasad Raju | Chief Financial Officer | Sell | 29,700 | $60.16 | $1.79M | 0 |
| Dec 22, 2025 | Prasad Raju | Chief Financial Officer | Sell | 10,000 | $55.95 | $559.5K | 0 |
| Oct 16, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 50,895 | $67.91 | $3.46M | 0 |
| Oct 13, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,076 | $66.60 | $71.7K | 0 |
| Oct 13, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 4,242 | $66.60 | $282.5K | 0 |
| Aug 16, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 13,081 | $58.15 | $760.7K | 0 |
| Aug 6, 2025 | Treco Douglas A | Director | Buy | 20,000 | $57.03 | $1.14M | 0 |
| Jul 16, 2025 | George Simeon | Director | Buy | 989,812 | $52.03 | $51.50M1.0% OS | 0 |
| May 28, 2025 | Patel Naimish | Chief Medical Officer | Sell | 3,932 | $35.94 | $141.3K | 0 |
| Apr 3, 2025 | Patel Naimish | Chief Medical Officer | Buy | 1,508 | $32.96 | $49.7K | 0 |
| Mar 20, 2025 | Bruno Julianne | Chief Operating Officer | Sell | 1,714 | $41.23 | $70.7K | 0 |
| Mar 20, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,185 | $41.23 | $131.3K | 0 |
| Mar 20, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 10,031 | $41.23 | $413.6K | 0 |
| Mar 20, 2025 | Prasad Raju | Chief Financial Officer | Sell | 2,197 | $41.23 | $90.6K | 0 |
| Mar 14, 2025 | Prasad Raju | Chief Financial Officer | Sell | 3,762 | $41.80 | $157.3K | 0 |
| Mar 10, 2025 | Bruno Julianne | Chief Operating Officer | Sell | 1,388 | $42.54 | $59.0K | 0 |
| Mar 10, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,966 | $42.67 | $169.2K | 0 |
| Mar 10, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 14,435 | $42.70 | $616.3K | 0 |
| Feb 26, 2025 | Greene John | Director | Buy | 7,000 | $44.85 | $313.9K | 0 |
| Feb 19, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 18,360 | $55.20 | $1.01M | 0 |
| Feb 18, 2025 | Bruno Julianne | Chief Operating Officer | Sell | 333 | $52.80 | $17.6K | 0 |
| Feb 18, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 18,568 | $54.21 | $1.01M | 0 |
| Feb 16, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 11,542 | $53.67 | $619.5K | 0 |
| Dec 2, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 15,000 | $55.10 | $826.6K | 0 |
| Nov 11, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $55.62 | $1.67M | 0 |
| Oct 13, 2024 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,089 | $46.28 | $50.4K | 0 |
| Oct 13, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 4,293 | $46.28 | $198.7K | 0 |
| Jun 20, 2024 | Bruno Julianne | Chief Operating Officer | Sell | 3,366 | $56.09 | $188.8K | 0 |
| Apr 15, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 19,582 | $59.91 | $1.17M | 0 |
| Mar 15, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $72.48 | $1.45M | 0 |
| Mar 14, 2024 | Prasad Raju | Chief Financial Officer | Sell | 3,524 | $72.69 | $256.2K | 0 |
| Mar 10, 2024 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,947 | $77.15 | $304.5K | 0 |
| Mar 10, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 14,385 | $77.04 | $1.11M | 0 |
| Feb 18, 2024 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,913 | $79.67 | $152.4K | 0 |
| Feb 18, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 6,370 | $79.67 | $507.5K | 0 |
| Feb 15, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $80.36 | $1.61M | 0 |
| Jan 29, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 50,000 | $60.51 | $3.03M | 0 |
| Jan 16, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $62.50 | $1.25M | 0 |
| May 30, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $64.88 | $1.62M | 0 |
| May 23, 2023 | Morrow Phuong Khanh | Chief Medical Officer | Sell | 2,527 | $65.91 | $166.6K | 0 |
| Apr 25, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $50.67 | $1.27M | 0 |
| Mar 29, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $44.46 | $1.11M | 0 |
| Mar 10, 2023 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,305 | $43.22 | $99.6K | 0 |
| Mar 10, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 9,444 | $43.22 | $408.2K | 0 |
| Feb 27, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $48.25 | $1.21M | 0 |
| Feb 18, 2023 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,950 | $48.26 | $94.1K | 0 |
Showing 1–50 of 92
1 / 2
CRSP Insider Buying Activity
The following table shows recent insider purchases of CRISPR Therapeutics AG (CRSP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Treco Douglas A | Director | Buy | 20,000 | $57.03 | $1.14M | 0 |
| Jul 16, 2025 | George Simeon | Director | Buy | 989,812 | $52.03 | $51.50M1.0% OS | 0 |
| Apr 3, 2025 | Patel Naimish | Chief Medical Officer | Buy | 1,508 | $32.96 | $49.7K | 0 |
| Feb 26, 2025 | Greene John | Director | Buy | 7,000 | $44.85 | $313.9K | 0 |
CRSP Insider Selling Activity
The following table shows recent insider sales of CRISPR Therapeutics AG (CRSP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,112 | $52.58 | $111.0K | 0 |
| Feb 18, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 6,967 | $52.58 | $366.3K | 0 |
| Jan 22, 2026 | Prasad Raju | Chief Financial Officer | Sell | 34,972 | $60.19 | $2.10M | 0 |
| Jan 20, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 90,000 | $57.40 | $5.17M | 0 |
| Jan 6, 2026 | Prasad Raju | Chief Financial Officer | Sell | 29,700 | $60.16 | $1.79M | 0 |
| Dec 22, 2025 | Prasad Raju | Chief Financial Officer | Sell | 10,000 | $55.95 | $559.5K | 0 |
| Oct 16, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 50,895 | $67.91 | $3.46M | 0 |
| Oct 13, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,076 | $66.60 | $71.7K | 0 |
| Oct 13, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 4,242 | $66.60 | $282.5K | 0 |
| Aug 16, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 13,081 | $58.15 | $760.7K | 0 |
| May 28, 2025 | Patel Naimish | Chief Medical Officer | Sell | 3,932 | $35.94 | $141.3K | 0 |
| Mar 20, 2025 | Bruno Julianne | Chief Operating Officer | Sell | 1,714 | $41.23 | $70.7K | 0 |
| Mar 20, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,185 | $41.23 | $131.3K | 0 |
| Mar 20, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 10,031 | $41.23 | $413.6K | 0 |
| Mar 20, 2025 | Prasad Raju | Chief Financial Officer | Sell | 2,197 | $41.23 | $90.6K | 0 |
| Mar 14, 2025 | Prasad Raju | Chief Financial Officer | Sell | 3,762 | $41.80 | $157.3K | 0 |
| Mar 10, 2025 | Bruno Julianne | Chief Operating Officer | Sell | 1,388 | $42.54 | $59.0K | 0 |
| Mar 10, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,966 | $42.67 | $169.2K | 0 |
| Mar 10, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 14,435 | $42.70 | $616.3K | 0 |
| Feb 19, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 18,360 | $55.20 | $1.01M | 0 |
| Feb 18, 2025 | Bruno Julianne | Chief Operating Officer | Sell | 333 | $52.80 | $17.6K | 0 |
| Feb 18, 2025 | Kulkarni Samarth | Chief Executive Officer | Sell | 18,568 | $54.21 | $1.01M | 0 |
| Feb 16, 2025 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 11,542 | $53.67 | $619.5K | 0 |
| Dec 2, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 15,000 | $55.10 | $826.6K | 0 |
| Nov 11, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $55.62 | $1.67M | 0 |
| Oct 13, 2024 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,089 | $46.28 | $50.4K | 0 |
| Oct 13, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 4,293 | $46.28 | $198.7K | 0 |
| Jun 20, 2024 | Bruno Julianne | Chief Operating Officer | Sell | 3,366 | $56.09 | $188.8K | 0 |
| Apr 15, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 19,582 | $59.91 | $1.17M | 0 |
| Mar 15, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $72.48 | $1.45M | 0 |
| Mar 14, 2024 | Prasad Raju | Chief Financial Officer | Sell | 3,524 | $72.69 | $256.2K | 0 |
| Mar 10, 2024 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,947 | $77.15 | $304.5K | 0 |
| Mar 10, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 14,385 | $77.04 | $1.11M | 0 |
| Feb 18, 2024 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,913 | $79.67 | $152.4K | 0 |
| Feb 18, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 6,370 | $79.67 | $507.5K | 0 |
| Feb 15, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $80.36 | $1.61M | 0 |
| Jan 29, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 50,000 | $60.51 | $3.03M | 0 |
| Jan 16, 2024 | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $62.50 | $1.25M | 0 |
| May 30, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $64.88 | $1.62M | 0 |
| May 23, 2023 | Morrow Phuong Khanh | Chief Medical Officer | Sell | 2,527 | $65.91 | $166.6K | 0 |
| Apr 25, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $50.67 | $1.27M | 0 |
| Mar 29, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $44.46 | $1.11M | 0 |
| Mar 10, 2023 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,305 | $43.22 | $99.6K | 0 |
| Mar 10, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 9,444 | $43.22 | $408.2K | 0 |
| Feb 27, 2023 | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $48.25 | $1.21M | 0 |
| Feb 18, 2023 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,950 | $48.26 | $94.1K | 0 |
CRSP Insiders
Similar Stocks to CRSP
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B